Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15020207rdf:typepubmed:Citationlld:pubmed
pubmed-article:15020207lifeskim:mentionsumls-concept:C0007452lld:lifeskim
pubmed-article:15020207lifeskim:mentionsumls-concept:C1267092lld:lifeskim
pubmed-article:15020207lifeskim:mentionsumls-concept:C0221464lld:lifeskim
pubmed-article:15020207lifeskim:mentionsumls-concept:C1522318lld:lifeskim
pubmed-article:15020207lifeskim:mentionsumls-concept:C0242606lld:lifeskim
pubmed-article:15020207lifeskim:mentionsumls-concept:C0056693lld:lifeskim
pubmed-article:15020207lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:15020207lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:15020207lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:15020207pubmed:issue2lld:pubmed
pubmed-article:15020207pubmed:dateCreated2004-3-15lld:pubmed
pubmed-article:15020207pubmed:abstractTextRecent studies in our lab and by others have indicated that cyclic ADP-ribose (cADPR) as a novel second messenger is importantly involved in vasomotor response in various vascular beds. However, the mechanism regulating cADPR production and actions remains poorly understood. The present study determined whether changes in redox status influence the production and action of cADPR in coronary arterial smooth muscle cells (CASMCs) and thereby alters vascular tone in these arteries. HPLC analyses demonstrated that xanthine (X, 40 microM)/xanthine oxidase (XO, 0.1 U/ml), a superoxide-generating system, increased the ADP-ribosyl cyclase activity by 59% in freshly isolated bovine CASMCs. However, hydrogen peroxide (H2O2, 1-100 microM) had no significant effect on ADP-ribosyl cyclase activity. In these CASMCs, X/XO produced a rapid increase in [Ca2+]i (Delta[Ca2+]i=201 nM), which was significantly attenuated by a cADPR antagonist, 8-Br-cADPR. Both inhibition of cADPR production by nicotinamide (Nicot) and blockade of Ca2+-induced Ca2+ release (CICR) by tetracaine (TC) and ryanodine (Rya) significantly reduced X/XO-induced rapid Ca2+ responses. In isolated, perfused, and pressurized small bovine coronary arteries, X at 2.5-80 microM with a fixed XO level produced a concentration-dependent vasoconstriction with a maximal decrease in arterial diameter of 45%. This X/XO-induced vasoconstriction was significantly attenuated by 8-Br-cADPR, Nicot, TC, or Rya. We conclude that superoxide activates cADPR production, and thereby mobilizes intracellular Ca2+ from the SR and produces vasoconstriction in coronary arteries.lld:pubmed
pubmed-article:15020207pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15020207pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15020207pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15020207pubmed:languageenglld:pubmed
pubmed-article:15020207pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15020207pubmed:citationSubsetIMlld:pubmed
pubmed-article:15020207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15020207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15020207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15020207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15020207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15020207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15020207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15020207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15020207pubmed:statusMEDLINElld:pubmed
pubmed-article:15020207pubmed:monthMarlld:pubmed
pubmed-article:15020207pubmed:issn0026-2862lld:pubmed
pubmed-article:15020207pubmed:authorpubmed-author:GuéXXlld:pubmed
pubmed-article:15020207pubmed:authorpubmed-author:ZouAi-PingAPlld:pubmed
pubmed-article:15020207pubmed:authorpubmed-author:LiPin-LanPLlld:pubmed
pubmed-article:15020207pubmed:authorpubmed-author:ZhangAndrew...lld:pubmed
pubmed-article:15020207pubmed:authorpubmed-author:TeggatzEric...lld:pubmed
pubmed-article:15020207pubmed:issnTypePrintlld:pubmed
pubmed-article:15020207pubmed:volume67lld:pubmed
pubmed-article:15020207pubmed:ownerNLMlld:pubmed
pubmed-article:15020207pubmed:authorsCompleteYlld:pubmed
pubmed-article:15020207pubmed:pagination159-67lld:pubmed
pubmed-article:15020207pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:meshHeadingpubmed-meshheading:15020207...lld:pubmed
pubmed-article:15020207pubmed:year2004lld:pubmed
pubmed-article:15020207pubmed:articleTitleEnhanced production and action of cyclic ADP-ribose during oxidative stress in small bovine coronary arterial smooth muscle.lld:pubmed
pubmed-article:15020207pubmed:affiliationDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.lld:pubmed
pubmed-article:15020207pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15020207pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15020207pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15020207lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15020207lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15020207lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15020207lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15020207lld:pubmed